These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1870213)

  • 21. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
    Ly A; Stamatatos L
    J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.
    Lusso P; Cocchi F; Balotta C; Markham PD; Louie A; Farci P; Pal R; Gallo RC; Reitz MS
    J Virol; 1995 Jun; 69(6):3712-20. PubMed ID: 7745720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 activation of HIV fusion.
    Sattentau QJ
    Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2.
    Dragic T; Alizon M
    J Virol; 1993 Apr; 67(4):2355-9. PubMed ID: 8095307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in the interaction of HIV-1 and HIV-2 with CD4.
    Looney DJ; Hayashi S; Nicklas M; Redfield RR; Broder S; Wong-Staal F; Mitsuya H
    J Acquir Immune Defic Syndr (1988); 1990; 3(7):649-57. PubMed ID: 1693676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusion from without directed by human immunodeficiency virus particles.
    Clavel F; Charneau P
    J Virol; 1994 Feb; 68(2):1179-85. PubMed ID: 8289347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
    Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.
    Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A
    J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective antiviral activity of synthetic soluble L-tyrosine and L-dopa melanins against human immunodeficiency virus in vitro.
    Montefiori DC; Zhou JY
    Antiviral Res; 1991 Jan; 15(1):11-25. PubMed ID: 1709802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
    Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
    Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of human immunodeficiency virus type 1 entry in the CDR2 loop of the CD4 glycoprotein.
    Brand D; Srinivasan K; Sodroski J
    J Virol; 1995 Jan; 69(1):166-71. PubMed ID: 7983707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants.
    Dedera D; Ratner L
    J Virol; 1991 Nov; 65(11):6129-36. PubMed ID: 1717715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
    Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
    J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replicative capacity, cytopathic effect and cell tropism of HIV.
    Fenyö EM; Albert J; Asjö B
    AIDS; 1989; 3 Suppl 1():S5-12. PubMed ID: 2514754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel human immunodeficiency virus strain cytopathic to megakaryocytic cells.
    Kunzi MS; Groopman JE
    Blood; 1993 Jun; 81(12):3336-42. PubMed ID: 8507871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.
    Stevenson M; Haggerty S; Lamonica C; Mann AM; Meier C; Wasiak A
    J Virol; 1990 Aug; 64(8):3792-803. PubMed ID: 1695254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.
    Gorry PR; Taylor J; Holm GH; Mehle A; Morgan T; Cayabyab M; Farzan M; Wang H; Bell JE; Kunstman K; Moore JP; Wolinsky SM; Gabuzda D
    J Virol; 2002 Jun; 76(12):6277-92. PubMed ID: 12021361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    J Virol; 2001 Jun; 75(12):5646-55. PubMed ID: 11356972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains.
    Shieh JT; Martín J; Baltuch G; Malim MH; González-Scarano F
    J Virol; 2000 Jan; 74(2):693-701. PubMed ID: 10623731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
    Willey RL; Theodore TS; Martin MA
    J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.